ID   CALR_CAEEL              Reviewed;         395 AA.
AC   P27798;
DT   01-AUG-1992, integrated into UniProtKB/Swiss-Prot.
DT   01-AUG-1992, sequence version 1.
DT   03-AUG-2022, entry version 180.
DE   RecName: Full=Calreticulin;
DE   Flags: Precursor;
GN   Name=crt-1; ORFNames=Y38A10A.5;
OS   Caenorhabditis elegans.
OC   Eukaryota; Metazoa; Ecdysozoa; Nematoda; Chromadorea; Rhabditida;
OC   Rhabditina; Rhabditomorpha; Rhabditoidea; Rhabditidae; Peloderinae;
OC   Caenorhabditis.
OX   NCBI_TaxID=6239;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=Bristol N2;
RX   PubMed=1627827; DOI=10.3109/10425179209020808;
RA   Smith M.J.;
RT   "A C. elegans gene encodes a protein homologous to mammalian
RT   calreticulin.";
RL   DNA Seq. 2:235-240(1992).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Bristol N2;
RX   PubMed=9851916; DOI=10.1126/science.282.5396.2012;
RG   The C. elegans sequencing consortium;
RT   "Genome sequence of the nematode C. elegans: a platform for investigating
RT   biology.";
RL   Science 282:2012-2018(1998).
RN   [3]
RP   PROTEOLYTIC CLEAVAGE, AND MUTAGENESIS OF ASP-182; ASP-225 AND ASP-253.
RX   PubMed=17371877; DOI=10.1074/jbc.m611051200;
RA   Taylor R.C., Brumatti G., Ito S., Hengartner M.O., Derry W.B., Martin S.J.;
RT   "Establishing a blueprint for CED-3-dependent killing through
RT   identification of multiple substrates for this protease.";
RL   J. Biol. Chem. 282:15011-15021(2007).
RN   [4]
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RX   PubMed=20153198; DOI=10.1016/j.cub.2009.12.061;
RA   Zahreddine H., Zhang H., Diogon M., Nagamatsu Y., Labouesse M.;
RT   "CRT-1/calreticulin and the E3 ligase EEL-1/HUWE1 control hemidesmosome
RT   maturation in C. elegans development.";
RL   Curr. Biol. 20:322-327(2010).
RN   [5]
RP   FUNCTION, AND INDUCTION BY ER STRESS.
RX   PubMed=24933177; DOI=10.1016/j.biocel.2014.06.005;
RA   Lim Y., Lee D., Kalichamy K., Hong S.E., Michalak M., Ahnn J., Kim D.H.,
RA   Lee S.K.;
RT   "Sumoylation regulates ER stress response by modulating calreticulin gene
RT   expression in XBP-1-dependent mode in Caenorhabditis elegans.";
RL   Int. J. Biochem. Cell Biol. 53:399-408(2014).
RN   [6]
RP   FUNCTION.
RX   PubMed=29346364; DOI=10.1371/journal.pgen.1007106;
RA   Offenburger S.L., Jongsma E., Gartner A.;
RT   "Mutations in Caenorhabditis elegans neuroligin-like glit-1, the apoptosis
RT   pathway and the calcium chaperone crt-1 increase dopaminergic
RT   neurodegeneration after 6-OHDA treatment.";
RL   PLoS Genet. 14:E1007106-E1007106(2018).
RN   [7]
RP   FUNCTION, INDUCTION, AND MUTAGENESIS OF 28-TRP--LEU-395.
RX   PubMed=32905769; DOI=10.1016/j.celrep.2020.108125;
RA   Burkewitz K., Feng G., Dutta S., Kelley C.A., Steinbaugh M., Cram E.J.,
RA   Mair W.B.;
RT   "Atf-6 Regulates Lifespan through ER-Mitochondrial Calcium Homeostasis.";
RL   Cell Rep. 32:108125-108125(2020).
CC   -!- FUNCTION: Molecular calcium-binding chaperone promoting folding,
CC       oligomeric assembly and quality control in the endoplasmic reticulum
CC       (ER) via the calreticulin/calnexin cycle (By similarity). This lectin
CC       may interact transiently with almost all of the monoglucosylated
CC       glycoproteins that are synthesized in the ER (By similarity). Probably
CC       by controlling the folding of extracellular matrix protein unc-
CC       52/Perlecan, may play a role in the formation of fibrous organelles, a
CC       hemidesmosome-like structure attaching muscles to the epidermis
CC       (PubMed:20153198). Protects dopaminergic neurons against oxidative
CC       stress-induced neurodegeneration (PubMed:29346364). May play a role in
CC       protection against ER stress (PubMed:24933177). Plays a role in
CC       modulating lifespan, acting by influencing ER calcium homeostasis
CC       (PubMed:32905769). {ECO:0000250|UniProtKB:P14211,
CC       ECO:0000269|PubMed:20153198, ECO:0000269|PubMed:24933177,
CC       ECO:0000269|PubMed:29346364}.
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum lumen.
CC   -!- INDUCTION: By ER stress in an xbp-1-dependent manner (PubMed:24933177).
CC       By aging (PubMed:32905769). {ECO:0000269|PubMed:24933177,
CC       ECO:0000269|PubMed:32905769}.
CC   -!- DOMAIN: Can be divided into a N-terminal globular domain, a proline-
CC       rich P-domain forming an elongated arm-like structure and a C-terminal
CC       acidic domain. The P-domain binds one molecule of calcium with high
CC       affinity, whereas the acidic C-domain binds multiple calcium ions with
CC       low affinity (By similarity). {ECO:0000250}.
CC   -!- DOMAIN: The interaction with glycans occurs through a binding site in
CC       the globular lectin domain. {ECO:0000250}.
CC   -!- DOMAIN: The zinc binding sites are localized to the N-domain.
CC       {ECO:0000250}.
CC   -!- PTM: Cleaved by caspase ced-3 in vitro. {ECO:0000269|PubMed:17371877}.
CC   -!- DISRUPTION PHENOTYPE: RNAi-mediated knockdown in a vab-10(e698) mutant
CC       background causes 45 percent embryonic lethality. In the surviving
CC       animals, causes a 14 percent larval lethality associated with the
CC       detachment of muscles from the epidermis.
CC       {ECO:0000269|PubMed:20153198}.
CC   -!- SIMILARITY: Belongs to the calreticulin family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X59589; CAA42159.1; -; Genomic_DNA.
DR   EMBL; BX284605; CCD69629.1; -; Genomic_DNA.
DR   PIR; S25851; S25851.
DR   RefSeq; NP_504575.1; NM_072174.3.
DR   AlphaFoldDB; P27798; -.
DR   SMR; P27798; -.
DR   BioGRID; 44045; 24.
DR   DIP; DIP-25701N; -.
DR   IntAct; P27798; 4.
DR   MINT; P27798; -.
DR   STRING; 6239.Y38A10A.5.1; -.
DR   World-2DPAGE; 0020:P27798; -.
DR   EPD; P27798; -.
DR   PaxDb; P27798; -.
DR   PeptideAtlas; P27798; -.
DR   EnsemblMetazoa; Y38A10A.5.1; Y38A10A.5.1; WBGene00000802.
DR   GeneID; 178997; -.
DR   KEGG; cel:CELE_Y38A10A.5; -.
DR   UCSC; Y38A10A.5.1; c. elegans.
DR   CTD; 178997; -.
DR   WormBase; Y38A10A.5; CE21562; WBGene00000802; crt-1.
DR   eggNOG; KOG0674; Eukaryota.
DR   GeneTree; ENSGT00950000182915; -.
DR   HOGENOM; CLU_018224_0_2_1; -.
DR   InParanoid; P27798; -.
DR   OMA; DYKDDPY; -.
DR   OrthoDB; 822188at2759; -.
DR   PhylomeDB; P27798; -.
DR   Reactome; R-CEL-901042; Calnexin/calreticulin cycle.
DR   PRO; PR:P27798; -.
DR   Proteomes; UP000001940; Chromosome V.
DR   Bgee; WBGene00000802; Expressed in embryo and 5 other tissues.
DR   GO; GO:0005737; C:cytoplasm; IDA:WormBase.
DR   GO; GO:0005788; C:endoplasmic reticulum lumen; IEA:UniProtKB-SubCell.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IBA:GO_Central.
DR   GO; GO:0005509; F:calcium ion binding; IDA:WormBase.
DR   GO; GO:0030246; F:carbohydrate binding; IEA:UniProtKB-KW.
DR   GO; GO:0051082; F:unfolded protein binding; IEA:InterPro.
DR   GO; GO:0030421; P:defecation; IGI:WormBase.
DR   GO; GO:0030968; P:endoplasmic reticulum unfolded protein response; IMP:WormBase.
DR   GO; GO:0031581; P:hemidesmosome assembly; IGI:WormBase.
DR   GO; GO:0048609; P:multicellular organismal reproductive process; IGI:WormBase.
DR   GO; GO:1903204; P:negative regulation of oxidative stress-induced neuron death; IMP:UniProtKB.
DR   GO; GO:0012501; P:programmed cell death; IGI:WormBase.
DR   GO; GO:0006457; P:protein folding; IBA:GO_Central.
DR   GO; GO:0010468; P:regulation of gene expression; IMP:WormBase.
DR   GO; GO:0045471; P:response to ethanol; IEP:WormBase.
DR   GO; GO:0009408; P:response to heat; IMP:WormBase.
DR   GO; GO:0030433; P:ubiquitin-dependent ERAD pathway; IBA:GO_Central.
DR   Gene3D; 2.10.250.10; -; 1.
DR   InterPro; IPR001580; Calret/calnex.
DR   InterPro; IPR018124; Calret/calnex_CS.
DR   InterPro; IPR009169; Calreticulin.
DR   InterPro; IPR009033; Calreticulin/calnexin_P_dom_sf.
DR   InterPro; IPR013320; ConA-like_dom_sf.
DR   PANTHER; PTHR11073; PTHR11073; 1.
DR   Pfam; PF00262; Calreticulin; 2.
DR   PIRSF; PIRSF002356; Calreticulin; 1.
DR   PRINTS; PR00626; CALRETICULIN.
DR   SUPFAM; SSF49899; SSF49899; 1.
DR   SUPFAM; SSF63887; SSF63887; 1.
DR   PROSITE; PS00803; CALRETICULIN_1; 1.
DR   PROSITE; PS00804; CALRETICULIN_2; 1.
DR   PROSITE; PS00805; CALRETICULIN_REPEAT; 3.
DR   PROSITE; PS00014; ER_TARGET; 1.
PE   1: Evidence at protein level;
KW   Calcium; Chaperone; Disulfide bond; Endoplasmic reticulum; Lectin;
KW   Metal-binding; Reference proteome; Repeat; Signal; Zinc.
FT   SIGNAL          1..15
FT                   /evidence="ECO:0000255"
FT   CHAIN           16..395
FT                   /note="Calreticulin"
FT                   /id="PRO_0000004180"
FT   REPEAT          186..197
FT                   /note="1-1"
FT   REPEAT          205..216
FT                   /note="1-2"
FT   REPEAT          222..233
FT                   /note="1-3"
FT   REPEAT          239..250
FT                   /note="1-4"
FT   REPEAT          254..264
FT                   /note="2-1"
FT   REPEAT          268..278
FT                   /note="2-2"
FT   REPEAT          282..292
FT                   /note="2-3"
FT   REGION          186..250
FT                   /note="4 X approximate repeats"
FT   REGION          ?..192
FT                   /note="N-domain"
FT   REGION          193..301
FT                   /note="P-domain"
FT   REGION          202..255
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          254..292
FT                   /note="3 X approximate repeats"
FT   REGION          302..395
FT                   /note="C-domain"
FT   REGION          340..395
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOTIF           392..395
FT                   /note="Prevents secretion from ER"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU10138"
FT   COMPBIAS        202..216
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        224..249
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        340..377
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        378..395
FT                   /note="Acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         105
FT                   /ligand="an alpha-D-glucoside"
FT                   /ligand_id="ChEBI:CHEBI:22390"
FT                   /evidence="ECO:0000250|UniProtKB:P14211"
FT   BINDING         107
FT                   /ligand="an alpha-D-glucoside"
FT                   /ligand_id="ChEBI:CHEBI:22390"
FT                   /evidence="ECO:0000250|UniProtKB:P14211"
FT   BINDING         124
FT                   /ligand="an alpha-D-glucoside"
FT                   /ligand_id="ChEBI:CHEBI:22390"
FT                   /evidence="ECO:0000250|UniProtKB:P14211"
FT   BINDING         131
FT                   /ligand="an alpha-D-glucoside"
FT                   /ligand_id="ChEBI:CHEBI:22390"
FT                   /evidence="ECO:0000250|UniProtKB:P14211"
FT   BINDING         312
FT                   /ligand="an alpha-D-glucoside"
FT                   /ligand_id="ChEBI:CHEBI:22390"
FT                   /evidence="ECO:0000250|UniProtKB:P14211"
FT   DISULFID        101..133
FT                   /evidence="ECO:0000250"
FT   MUTAGEN         28..395
FT                   /note="Missing: In bz29; extended lifespan."
FT                   /evidence="ECO:0000269|PubMed:32905769"
FT   MUTAGEN         182
FT                   /note="D->E: Partial reduction in ced-3-mediated cleavage;
FT                   when associated with E-225 and E-253."
FT                   /evidence="ECO:0000269|PubMed:17371877"
FT   MUTAGEN         225
FT                   /note="D->E: Partial reduction in ced-3-mediated cleavage;
FT                   when associated with E-182 and E-253."
FT                   /evidence="ECO:0000269|PubMed:17371877"
FT   MUTAGEN         253
FT                   /note="D->E: Partial reduction in ced-3-mediated cleavage;
FT                   when associated with E-182 and E-225."
FT                   /evidence="ECO:0000269|PubMed:17371877"
SQ   SEQUENCE   395 AA;  45616 MW;  35CA7D2EC1D56B03 CRC64;
     MKSLCLLAIV AVVSAEVYFK EEFNDASWEK RWVQSKHKDD FGAFKLSAGK FFDVESRDQG
     IQTSQDAKFY SRAAKFDKDF SNKGKTLVIQ YTVKHEQGID CGGGYVKVMR ADADLGDFHG
     ETPYNVMFGP DICGPTRRVH VILNYKGENK LIKKEITCKS DELTHLYTLI LNSDNTYEVK
     IDGESAQTGS LEEDWDLLPA KKIKDPDAKK PEDWDEREYI DDAEDAKPED WEKPEHIPDP
     DAKKPEDWDD EMDGEWEPPM IDNPEYKGEW KPKQIKNPAY KGKWIHPEIE NPEYTPDDEL
     YSYESWGAIG FDLWQVKSGT IFDNIIITDS VEEAEAHAAE TFDKLKTVEK EKKEKADEET
     RKAEEEARKK AEEEKEAKKD DDEEEKEEEE GHDEL
//
